{"schema_version":"1","generated_at":"2026-11-05T05:28:10.792Z","data_as_of":null,"url":"https://www.findmykol.com/kol/wei-ming-kao","json_url":"https://www.findmykol.com/kol/wei-ming-kao/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"wei-ming-kao","name":"Wei-Ming Kao","credential":"MD","specialty":"Pediatric Hematology-Oncology","specialty_raw":"Pediatric Hematology-Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Bristol-Myers Squibb","institution_url":"https://www.findmykol.com/institution/bristol-myers-squibb","city":"Palo Alto","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1124339114","orcid":"0000-0002-3911-5150","openalex":"A5067278693"},"summary":"Wei-Ming Kao is an Oncology physician affiliated with Bristol-Myers Squibb. OpenAlex indexes 22 publications with 1,791 citations (h-index 9).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":22,"cited_by_count":1791,"h_index":9,"latest_activity_year":2026,"emerging":true,"source":"works"},"publications":{"total":22,"shown":5,"withheld":17,"matched_by":"OpenAlex author record","recent":[{"title":"Arlocabtagene autoleucel: a GPRC5D-targeted CAR T-cell therapy for heavily pretreated relapsed/refractory multiple myeloma","year":2026,"journal":"Blood","source_url":"https://doi.org/10.1182/blood.2025030750","status":"verified"},{"title":"PA-358 Post-Infusion Immunophenotypic And Functional Characteristics Of Arlocabtagene Autoleucel (Arlo-Cel) In A First-In-Human (FiH), Phase 1 Trial In Relapsed/Refractory Multiple Myeloma (RRMM)","year":2026,"journal":"Clinical Lymphoma Myeloma & Leukemia","source_url":"https://doi.org/10.1016/s2152-2650(26)03721-3","status":"verified"},{"title":"MM-1119: Arlocabtagene Autoleucel in Patients With Heavily Pretreated Relapsed/Refractory Multiple Myeloma: Final Analysis From the Phase 1 Study","year":2026,"journal":"Clinical Lymphoma Myeloma & Leukemia","source_url":"https://doi.org/10.1016/s2152-2650(26)02987-3","status":"verified"},{"title":"MM-1223: Arlocabtagene Autoleucel, a GPRC5D-Targeted CAR T-Cell Therapy for Patients With Relapsed/Refractory Multiple Myeloma: Updated Phase 1 Safety and Efficacy Results in Patients With 1–3 Prior Regimens","year":2026,"journal":"Clinical Lymphoma Myeloma & Leukemia","source_url":"https://doi.org/10.1016/s2152-2650(26)03008-9","status":"verified"},{"title":"POSTER: MM-1119: Arlocabtagene Autoleucel in Patients With Heavily Pretreated Relapsed/Refractory Multiple Myeloma: Final Analysis From the Phase 1 Study","year":2026,"journal":"Clinical Lymphoma Myeloma & Leukemia","source_url":"https://doi.org/10.1016/s2152-2650(26)01413-8","status":"verified"}],"source":"works"},"contact":{"address_1":"725 WELCH RD","city":"Palo Alto","state":"CA","zip":"943041601","phone":"650-497-8000","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1124339114","source":"identity"},"similar":[{"name":"Yixin Li","slug":"yixin-li","institution":"Bristol-Myers Squibb","url":"https://www.findmykol.com/kol/yixin-li","json_url":"https://www.findmykol.com/kol/yixin-li/profile.json"},{"name":"Alan J. Korman","slug":"alan-korman","institution":"Bristol-Myers Squibb","url":"https://www.findmykol.com/kol/alan-korman","json_url":"https://www.findmykol.com/kol/alan-korman/profile.json"},{"name":"Robert Plenge","slug":"robert-plenge","institution":"Bristol-Myers Squibb","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/robert-plenge","json_url":"https://www.findmykol.com/kol/robert-plenge/profile.json"},{"name":"Ray Hershberger","slug":"ray-hershberger","institution":"Bristol-Myers Squibb","specialty":"Advanced Heart Failure and Transplant Cardiology","url":"https://www.findmykol.com/kol/ray-hershberger","json_url":"https://www.findmykol.com/kol/ray-hershberger/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":17}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2025-02-04","provider_certified":"2025-02-04","collected_at":"2026-11-04T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"}},"methodology_url":"https://www.findmykol.com/about#methodology"}